29.11.2004
Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trial
H.-P. Bestehorn, F.-J. Neumann, H.J. Büttner, P. Betz, P. Stürzenhofecker, E. von Hodenberg, A. Verdun, L. Levai, J.P. Monassier, H. Roskamm
Journal of the American College of Cardiology, 2004; 43: 2160-2165